BigSur Wealth Management LLC Purchases 1,364 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

BigSur Wealth Management LLC grew its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 51.7% during the 4th quarter, Holdings Channel.com reports. The firm owned 4,000 shares of the company’s stock after acquiring an additional 1,364 shares during the period. BigSur Wealth Management LLC’s holdings in GE HealthCare Technologies were worth $313,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. D1 Capital Partners L.P. purchased a new stake in GE HealthCare Technologies in the third quarter worth approximately $268,159,000. Van ECK Associates Corp bought a new stake in shares of GE HealthCare Technologies in the 3rd quarter worth approximately $208,513,000. State Street Corp boosted its stake in shares of GE HealthCare Technologies by 7.8% in the 3rd quarter. State Street Corp now owns 18,615,890 shares of the company’s stock valued at $1,747,101,000 after purchasing an additional 1,347,114 shares in the last quarter. Massachusetts Financial Services Co. MA bought a new position in shares of GE HealthCare Technologies during the 3rd quarter valued at $93,713,000. Finally, Marshall Wace LLP purchased a new position in GE HealthCare Technologies in the 2nd quarter worth $63,639,000. 82.06% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the company’s stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the sale, the chief executive officer now owns 24,298 shares in the company, valued at approximately $2,101,291.04. This represents a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.27% of the stock is owned by corporate insiders.

Analyst Ratings Changes

GEHC has been the subject of several analyst reports. Evercore ISI upped their price target on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a research report on Tuesday, October 1st. Wells Fargo & Company raised their price target on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and decreased their price target for the stock from $84.00 to $74.00 in a research note on Thursday, September 26th. Stifel Nicolaus increased their price objective on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research note on Monday, September 30th. Finally, Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their target price for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. One analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $96.00.

GE HealthCare Technologies Trading Down 0.3 %

NASDAQ:GEHC opened at $84.74 on Monday. GE HealthCare Technologies Inc. has a 12 month low of $71.31 and a 12 month high of $94.55. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. The company has a 50-day moving average price of $81.98 and a 200-day moving average price of $84.43. The stock has a market cap of $38.72 billion, a price-to-earnings ratio of 23.28, a P/E/G ratio of 2.80 and a beta of 1.11.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, beating the consensus estimate of $1.06 by $0.08. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The business had revenue of $4.86 billion for the quarter, compared to analysts’ expectations of $4.87 billion. During the same period in the previous year, the firm posted $0.99 EPS. The business’s revenue was up .9% on a year-over-year basis. Equities analysts predict that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.17%. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date of this dividend is Tuesday, January 14th. GE HealthCare Technologies’s dividend payout ratio is presently 3.30%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.